Weight Gain and Metabolic Changes in Studies of Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder

Thursday, October 20, 2011

Stephen Murray, M.B.A., Pharm.D., Bristol-Myers Squibb, Plainsboro, NJ

Joan Zhao, Ph.D., Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ

George Manos, Ph.D., Bristol-Myers Squibb, Wallingford, CT

Ray Mankoski, M.D., Ph.D., Bristol-Myers Squibb, Plainsboro, NJ

Ron Marcus, M.D., Bristol-Myers Squibb, Wallingford, CT

Robert D. McQuade, Ph.D., Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ

Sabrina V. Marler, M.S., Global Biometric Sciences, Bristol-Myers Squibb, Wallingford, CT

Robert A. Forbes, Ph.D., Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ

Christoph U. Correll, M.D., Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 2.40 Weight Gain and Metabolic Changes in Studies of Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder